Tag: Novo Nordisk diabetes drug Victoza

Novo Nordisk diabetes drug Victoza bags FDA approval for heart diseases

pharmanewsdaily- August 26, 2017

Danish pharma firm Novo Nordisk has secured the approval from the U.S. Food and Drug Administration (FDA) for using its diabetes drug Victoza (liraglutide) to ... Read More